Сравнение

Buserelin vs. Plecanatid

Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.

Идентичность

Категория

Исследования (прочее)

Номер CAS

57982-77-1

467426-54-6

Молекулярная масса

1239.42 g/mol

1682 g/mol

Период полувыведения

нет данных

Последовательность

нет данных

Механизм действия

Buserelin

Buserelin is a potent GnRH agonist: after an initial stimulatory surge ('flare'), continuous receptor occupancy causes downregulation and thereby suppression of LH, FSH and the downstream sex hormones.

Plecanatid

Plecanatide is structurally analogous to the body's own uroguanylin and, like it, activates the GC-C receptor at the gut surface, raising cGMP and fluid secretion. Its pH-dependent activity shifts the effect toward the proximal small intestine.

Доказательная база

Наивысшая доказательность

РКИ на людях

Исследования

из них на людях

Зафиксированные эффекты

Открытые противоречия

Задокументированные нежелательные явления

Правовой статус

Country	Buserelin	Plecanatid
Германия	Рецептурный	Не одобрено
США	Не одобрено	Рецептурный

Полные записи

Frequently asked questions

What is the difference between Buserelin and Plecanatid?: Buserelin is classified as "Исследования (прочее)", while Plecanatid is classified as "Исследования (прочее)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Plecanatid: Plecanatide is a 16-amino-acid analog of the body's own uroguanylin and a guanylate cyclase-C (GC-C) agonist. It is approved for chronic idiopathic constipation (CIC) and IBS with constipation (IBS-C). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Buserelin or Plecanatid?: The highest available evidence level is "РКИ на людях" for Buserelin and "РКИ на людях" for Plecanatid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Buserelin and Plecanatid in Germany and the United States?: Германия: Buserelin — Рецептурный, Plecanatid — Не одобрено. США: Buserelin — Не одобрено, Plecanatid — Рецептурный. These are factual summaries with source and review date on the individual pages.

Country

Buserelin

Plecanatid

Германия

Рецептурный

Не одобрено

США

Не одобрено

Рецептурный

Frequently asked questions

What is the difference between Buserelin and Plecanatid?

Buserelin is classified as "Исследования (прочее)", while Plecanatid is classified as "Исследования (прочее)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Plecanatid: Plecanatide is a 16-amino-acid analog of the body's own uroguanylin and a guanylate cyclase-C (GC-C) agonist. It is approved for chronic idiopathic constipation (CIC) and IBS with constipation (IBS-C). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Buserelin or Plecanatid?

The highest available evidence level is "РКИ на людях" for Buserelin and "РКИ на людях" for Plecanatid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Buserelin and Plecanatid in Germany and the United States?

Германия: Buserelin — Рецептурный, Plecanatid — Не одобрено. США: Buserelin — Не одобрено, Plecanatid — Рецептурный. These are factual summaries with source and review date on the individual pages.